معرفی
Professor Martin Empting is a leading researcher in medicinal chemistry and anti-infective drug discovery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), affiliated with Saarland University. He leads the research group focused on Antiviral & Antivirulence Agents, developing synthetic drug molecules targeting bacterial and viral pathogens. His academic background includes a doctorate from the Technical University of Darmstadt and a habilitation in Pharmaceutical and Medicinal Chemistry from Saarland University.
Empting's research interests span:
- Fragment-Based Drug Design
- Targeted Protein Degradation
- Quorum Sensing Inhibition
- Anti-Virulence Strategies
- Herpesviral Infections
- Pseudomonas aeruginosa pathogenesis
Recent publications reveal a strong trend in dual-targeting strategies, particularly combining traditional antibiotics with quorum sensing inhibitors to combat biofilm-related infections. His research bridges virology and bacteriology, with significant contributions to understanding and disrupting pathogen communication systems. The development of nanoparticle-based delivery systems further highlights his translational approach to overcoming drug resistance.
Scientific awards received include:
- Dr. Anton Keller Foundation Prize
- Family Bottling Foundation Prize
Empting conducts independent research following a postdoctoral period at HIPS. He supervises a research group focused on anti-infective development but no specific students are named in the provided materials. His laboratory develops innovative assays for target validation and employs advanced technologies like phage display and fragment-based design.
